<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Abbott MediaRoom (Innovation )</title>
<link>https://abbott.mediaroom.com/</link>
<description></description>
<item>
<title>Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes</title>
<link>https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes</link>
<description></description>
<pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-05-27-Abbott-secures-CE-Mark-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes</guid>
<enclosure url="https://mmx.prnewswire.com/media/MS1849056/Full_size_jpg-ADC-Photo-_Sensor_Hand-300_dpi.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Abbott to highlight expanding cancer diagnostic portfolio and clinical evidence at Digestive Disease Week (DDW) 2026</title>
<link>https://abbott.mediaroom.com/press-releases?item=124750</link>
<description></description>
<pubDate>Thu, 30 Apr 2026 09:00:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/press-releases?item=124750</guid>
</item>
<item>
<title>Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform</title>
<link>https://abbott.mediaroom.com/2026-04-28-Abbott-receives-FDA-clearance-and-CE-Mark-for-next-generation-Ultreon-TM-3-0-AI-powered-coronary-imaging-platform</link>
<description></description>
<pubDate>Tue, 28 Apr 2026 09:00:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-04-28-Abbott-receives-FDA-clearance-and-CE-Mark-for-next-generation-Ultreon-TM-3-0-AI-powered-coronary-imaging-platform</guid>
<enclosure url="https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026</title>
<link>https://abbott.mediaroom.com/2026-04-25-Abbott-showcases-strength-of-its-technologies-to-address-abnormal-heart-rhythms-with-late-breaking-clinical-data-at-Heart-Rhythm-Society-2026</link>
<description></description>
<pubDate>Sat, 25 Apr 2026 12:30:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-04-25-Abbott-showcases-strength-of-its-technologies-to-address-abnormal-heart-rhythms-with-late-breaking-clinical-data-at-Heart-Rhythm-Society-2026</guid>
<enclosure url="https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test</title>
<link>https://abbott.mediaroom.com/2026-04-17-New-data-at-AACR-2026-demonstrate-advancements-in-Cancerguard-R-Multi-Cancer-Early-Detection-Test</link>
<description></description>
<pubDate>Fri, 17 Apr 2026 15:30:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-04-17-New-data-at-AACR-2026-demonstrate-advancements-in-Cancerguard-R-Multi-Cancer-Early-Detection-Test</guid>
<enclosure url="https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
</channel>
</rss>
